Compare ORN & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORN | OVID |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.0M | 522.6M |
| IPO Year | 2007 | 2017 |
| Metric | ORN | OVID |
|---|---|---|
| Price | $12.02 | $2.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $16.25 | $4.60 |
| AVG Volume (30 Days) | 417.6K | ★ 1.8M |
| Earning Date | 04-28-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 220.00 | 3.90 |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $852,260,000.00 | $7,252,000.00 |
| Revenue This Year | $8.50 | N/A |
| Revenue Next Year | $7.83 | $19.34 |
| P/E Ratio | $103.50 | ★ N/A |
| Revenue Growth | 7.01 | ★ 1181.27 |
| 52 Week Low | $6.44 | $0.48 |
| 52 Week High | $17.40 | $3.11 |
| Indicator | ORN | OVID |
|---|---|---|
| Relative Strength Index (RSI) | 31.77 | 40.47 |
| Support Level | $11.39 | $2.18 |
| Resistance Level | $13.17 | $2.38 |
| Average True Range (ATR) | 0.70 | 0.15 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 20.97 | 7.83 |
Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.